8-K
filed November 8, 2022, 6:59 PM ET
ticker SGRY
CIK 0001638833
earnings
confidence high
sentiment positive
materiality 0.75
Surgery Partners Q3 revenue +11% to $620.6M, Adj EBITDA $96.2M, reaffirms FY guidance
Surgery Partners, Inc.
2022-Q3 EPS reported
-$0.35
revenue$1,832,200,000
- Revenue $620.6M (+11.0% YoY); same-facility revenue +5.1% (cases +3.3%, rev/case +1.8%).
- Net loss $25.0M vs $22.9M loss; Adjusted EBITDA $96.2M (+26% YoY); margin 15.5% (+180bps).
- Reaffirms FY2022 Adj EBITDA $375M-$385M; revenue $2.5-$2.55B.
- YTD deployed $240M on acquisitions (12 facilities) at sub-8x EBITDA; added 150+ physicians.
- Liquidity ~$500M ($154.8M cash + $342M revolver capacity); net debt/EBITDA 6.0x.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 1.0
Surgery Partners, Inc. reported Full year 2022 results: revenue $2.5 billion to $2.55 billion. Guidance reaffirmed.
- Period
- Full year 2022
- Revenue
- $2.5 billion to $2.55 billion
- Guidance
- reaffirmed
- Result
- guidance update
Exact text from the filing
The Company reaffirms projected 2022 Adjusted EBITDA of $375 million to $385 million and anticipates revenue in the range of $2.5 billion to $2.55 billion.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 1.0
Surgery Partners, Inc. reported Third quarter ended September 30, 2022 results: revenue $620.6 million, net income -$25.0 million.
- Period
- Third quarter ended September 30, 2022
- Revenue
- $620.6 million
- Net income
- -$25.0 million
- Result
- reported results
Exact text from the filing
Revenue for the third quarter of 2022 increased 11.0% to $620.6 million from $559.2 million for the third quarter of 2021. Same-facility revenues for the third quarter of 2022 increased 5.1% from the same period last year, with an increase in revenue per case of 1.8% and an increase in same-facility cases of 3.3%. For the third quarter of 2022, the Company’s net 1 loss attributable to common stockholders and Adjusted EBITDA was $25.0 million and $96.2 million, respectively, compared to $22.9 million and $76.4 million, respectively, for the same period last year.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.